Crossref
γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data
Clinical Investigation · 2011-08 · 1 (8) · 1175-1194
DOI: 10.4155/cli.11.86 ↗At a glance
Journal article in Clinical Investigation, 2011-08. Written by Francesco Panza and 5 co-authors. Cited 2 times so far (Crossref); 172 references.
Topics: Demenz
Abstract (original language)
Tiivistelmää ei ole saatavilla.
Cite
APA
Panza, F., Frisardi, V., Imbimbo, B. P., Seripa, D., Solfrizzi, V., & Pilotto, A. (2011). γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data. Clinical Investigation, 1(8), 1175-1194. https://doi.org/10.4155/cli.11.86
Vancouver
Panza F, Frisardi V, Imbimbo BP, Seripa D, Solfrizzi V, Pilotto A. γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data. Clinical Investigation. 2011;1(8):1175-1194. doi:10.4155/cli.11.86
BibTeX
@article{Panza2011,
author = {Panza, Francesco and Frisardi, Vincenza and Imbimbo, Bruno P and Seripa, Davide and Solfrizzi, Vincenzo and Pilotto, Alberto},
title = {γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data},
journal = {Clinical Investigation},
year = {2011},
volume = {1},
number = {8},
pages = {1175--1194},
doi = {10.4155/cli.11.86}
}
EUVIMED